« Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis SSC ISTH » RecommandationsPar SFTH5 mars 2024 Détails
« Assays to quantify fibrinolysis: strengths and limitations SSC fibrinolysis » RecommandationsPar SFTH5 mars 2024 Détails
« Sepsis-induced coagulopathy in the management of sepsis SSC ISTH » RecommandationsPar SFTH5 mars 2024 Détails
« Recommendation on the nomenclature for anticoagulants SSC Control of Anticoagulation » RecommandationsPar SFTH5 mars 2024 Détails
« Anticoagulation in adult patients supported with extracorporeal membrane oxygenation (ECMO SSC Perioperative and Critical Care Haemostasis and Thrombosis » RecommandationsPar SFTH5 mars 2024 Détails
ISTH guidelines for treatment of thrombotic thrombocytopenic purpura RecommandationsPar SFTH5 mars 2024 Détails
ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura RecommandationsPar SFTH5 mars 2024 Détails
Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis of VWD: a systematic review and meta-analysis RecommandationsPar SFTH5 mars 2024 Détails
ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease RecommandationsPar SFTH5 mars 2024 Détails
ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease RecommandationsPar SFTH5 mars 2024 Détails